Brimonidine Tartate 0.2% 10mL

NDC: 61314-143-10

Brimonidine Tartrate 0.2% Ophthalmic Solution, 10 mL — Bausch & Lomb

Indications and Usage

Indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The IOP-lowering efficacy may diminish over time in some patients.

Dosage and Administration

Instill one drop in the affected eye(s) three times daily, approximately 8 hours apart. If more than one topical ophthalmic product is used, administer the products at least 5 minutes apart.

Warnings and Precautions

• May potentiate vascular insufficiency; use caution in patients with severe cardiovascular disease, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, or thromboangiitis obliterans
• May cause fatigue and drowsiness that can impair the ability to drive or operate machinery
• Avoid contamination of the container tip and solution
• Contains benzalkonium chloride, which may be absorbed by soft contact lenses; remove lenses before use and wait 15 minutes before reinserting

Contraindications

Contraindicated in neonates and infants under 2 years of age and in patients with known hypersensitivity to any component.

Adverse Reactions

Common adverse reactions, occurring in approximately 10 to 30% of patients, include oral dryness, ocular hyperemia, burning and stinging, headache, blurred vision, foreign body sensation, fatigue and drowsiness, conjunctival follicles, ocular allergic reactions, and ocular pruritus.

Storage and Handling

Store at 15°C to 25°C (59°F to 77°F).

How Supplied

Supplied as a sterile solution in plastic dropper bottles, including a 10 mL fill size.

Professional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.